Akcea Therapeutics, Inc. Severance Costs
Akcea Therapeutics, Inc. reported Severance Costs of $1.80 million for the 9-month period ending 2019-09-30, per its 10-Q filed 2019-11-06.
Discontinued › Expense Statement › Operating Expenses
us-gaap:SeveranceCosts1 · last filed 2019-11-06
- 2019-09-30: Severance Costs 9 month $1.80M.
| Period end | Severance Costs 9 month |
|---|---|
| 2019-09-30 | $1.80M 10-Q · filed 2019-11-06 |